文献速递甲状腺与颈部外科

细针穿刺与Bethesda系统:1228例手术患者组织病理学相关性

Fine needle aspiration and the Bethesda system: Correlation with histopathology in 1,228 surgical patients.
PubMed 文献 · Surgery · 2021-06-13

本研究回顾性分析2010至2019年间单中心1228例因优势甲状腺结节行细针穿刺并接受甲状腺切除术的患者,按Bethesda六分类比较穿刺结果与最终组织病理恶性率。总体恶性率53%,各分类恶性率分别为无诊断性29%、良性11%、AUS/FLUS 51%、FN/SFN 47%、SFM 84%、恶性98%,假阳性率1%,假阴性率7-11%。

要点

  • 甲状腺结节细针穿刺Bethesda分类与最终病理恶性率呈明确梯度。
  • 假阴性率7-11%,良性穿刺结果仍需结合临床随访。

核心结论

  • 接受甲状腺切除术的优势结节患者中,细针穿刺总体恶性率为53%。
  • 假阴性率和假阳性率均在手术患者人群的报道范围内。
  • 多数AUS/FLUS、FN/SFN和SFM结果且潜在恶性的患者接受了适当的手术切除。

研究设计与样本

  • 单学术机构2010至2019年前瞻性收集数据的回顾性综述。
  • 纳入1228例因优势甲状腺结节行细针穿刺并接受甲状腺切除术的患者。
  • 按Bethesda系统全部6个分类分层,将穿刺结果与最终组织病理中索引结节恶性进行比较。

主要发现

  • 1228例患者总体恶性率为53%。
  • Bethesda分类恶性率:无诊断性29%,良性11%,AUS/FLUS 51%,FN/SFN 47%,SFM 84%,恶性98%。
  • 假阳性率为1%,假阴性率范围为7%至11%。

临床怎么用

  • 细针穿刺Bethesda分类可用于预估甲状腺结节恶性风险并指导手术决策。
  • 对AUS/FLUS和FN/SFN结果应结合临床和超声特征综合评估是否手术。
  • 良性穿刺结果需考虑7-11%的假阴性可能,不宜完全排除恶性。

局限性

  • 回顾性设计。
  • 仅纳入接受甲状腺切除术的患者,存在选择偏倚。
  • 单中心数据,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fine-needle aspiration combined with the Bethesda System for Reporting Thyroid Cytopathology is indispensable in the diagnostic evaluation of thyroid nodules. Their increased detection over the last few decades mandates the determination of which thyroid nodules require surgical management for malignancy. This study examines the correlation of fine-needle aspiration to final histopathology of dominant thyroid nodules in a large series of surgical patients undergoing thyroidectomy at a single academic institution. METHODS: A retrospective review of prospectively collected data of 1,228 patients who underwent fine-needle aspiration for a dominant thyroid nodule and thyroidectomy from a single institution between 2010 and 2019 was performed. The cases were stratified into all 6 Bethesda categories. Fine-needle aspiration results were compared to index thyroid nodule malignancy on final histopathology. RESULTS: Of 1,228 patients who underwent thyroidectomy, the overall malignancy rate was 53%. When fine-needle aspiration was stratified by the Bethesda System for Reporting Thyroid Cytopathology, malignancy rate was 29% for nondiagnostic; 11% for benign; 51% for atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS); 47% for follicular neoplasm/suspicious for follicular neoplasm (FN/SFN); 84% for suspicious for malignancy (SFM); and 98% for malignant results on final histopathology. There was a false positive rate of 1% and false negative rate ranging from 7 to 11%. CONCLUSION: Fine-needle aspiration of a dominant thyroid nodule in patients who underwent thyroidectomy had an overall malignancy rate of 53%. False negative and false positive rates are within the reported range in surgical patient populations. The majority of patients with AUS/FLUS, FN/SFN and SFM results with underlying malignancy received the appropriate surgical resection.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Linhares SM, Handelsman R, Picado O, et al. Fine needle aspiration and the Bethesda system: Correlation with histopathology in 1,228 surgical patients. Surgery. 2021. PMID: 34134896. doi:10.1016/j.surg.2021.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。